Kamasutra™ Exotic Vodka With Herborium Natural Herbs Moves To National Distribution First 1000 Cases Ordered
FORT LEE, N.J., Aug. 15, 2012 /PRNewswire/ -- Herborium Group, Inc., (HBRM) www.herborium.com, a Botanical Therapeutics® Company is excited to announce that a distribution of Kamasutra™ Exotic Vodka with herbal formula provided by Herborium, a pioneering specialty drink now available for the first time in the US, has officially started with a first wholesale order of 1000 cases.
"Such an immediate and large commercial interest is unprecedented for a novelty product like Kamasutra™ Vodka," commented Dr. Agnes P. Olszewski, CEO of Herborium. "After the product flew off the shelves during extremely successful unveiling in a Super Buy-Rite in New Jersey, we knew we have a winner. This order however is a confirmation that the alcoholic beverage industry also recognizes the great potential of this product to become a serious player in a rapidly growing segment of the $4 billion US market for flavor vodka," added Olszewski.
Kamasutra™ Vodka is the first-ever alcoholic beverage creation developed and endorsed by herbaceutical science and will appeal to a wider segment of experimental, progressive adult beverage drinkers.
The Social Media Marketing Campaign for Kamasutra™ Vodka commences this week, on Friday, August 17th and it will also include a co-promotion of Herbarium's proprietary Women and Men Sexual Health formulas: Lasting Pleasure® and Lasting Power® to be launched in the Fall of 2012.
"We are convinced that this is a first step in a direction of a great success. Our short term and long term revenues projections for Kamasutra™ Vodka and the sexual health products are most encouraging and we expect them to have a significant impact on the growth of the company," Concluded Dr. Olszewski.
About Herborium Group, Inc.
Herborium Group, Inc., a Botanical Therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company uses clinical validation to establish and maintain a differential advantage. The company sells its products in the US and Europe. For more information, please visit www.herborium.com and www.acnease.com
One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends." We cannot promise future returns. Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events. The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission.
For more information please inquire: Investorsrelations@herborium.com
SOURCE Herborium Group, Inc.